Showing results (71-80 of 4,234) with videos related to
Sort By:
Pageof 424
Journal for Immunotherapy of Cancer|May 8, 2020
Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignanciesJason Cham, Li Zhang, Serena Kwek, et al.Journal for Immunotherapy of Cancer|May 8, 2020
Efficacy of immune checkpoint inhibitors for in-transit melanomaEmilia Nan Tie, Julia Lai-Kwon, Michael Alexander Rtshiladze, et al.Journal for Immunotherapy of Cancer|May 8, 2020
Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trialLu Xie, Jie Xu, Xin Sun, et al.Journal for Immunotherapy of Cancer|April 10, 2020
Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophagesMarta Di Martile, Valentina Farini, Francesca Maria Consonni, et al.Journal for Immunotherapy of Cancer|April 22, 2020
Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanismsAlexander J Neuwelt, Abigail K Kimball, Amber M Johnson, et al.Journal for Immunotherapy of Cancer|October 23, 2019
Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymomaArun Rajan, Christopher R Heery, Anish Thomas, et al.Journal for Immunotherapy of Cancer|October 24, 2019
Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinomaPooja Ghatalia, Jennifer Gordetsky, Fengshen Kuo, et al.Journal for Immunotherapy of Cancer|October 24, 2019
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapiesZijun Y Xu-Monette, Jianyong Li, Yi Xia, et al.Journal for Immunotherapy of Cancer|October 26, 2019
Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcomaIndu Ramachandran, Daniel E Lowther, Rebecca Dryer-Minnerly, et al.Journal for Immunotherapy of Cancer|October 27, 2019
Immunogenicity of prostate cancer is augmented by BET bromodomain inhibitionWendy Mao, Ali Ghasemzadeh, Zachary T Freeman, et al.Pageof 424